TMTC Logo
|

Why South Asian Couples in the UK Face Longer Waits for Egg Donors - and What Options Are Available

As demand for donor egg IVF rises across the UK, South Asian patients continue to face some of the longest waits for a suitable donor. Here's why, and what can be done about it.
17 July 20268m
Dr Kate Maclaran
Dr Shabana Bora

Consultants in Reproductive Medicine, Alma Fertility, UK

South Asian couple consulting a female doctor in a medical office

A Growing Demand for Donor Egg IVF

Donor egg treatment is fast becoming one of the defining stories in UK fertility care. According to the HFEA's Fertility Treatment 2023: Trends and Figures report, almost 21,000 babies were born through IVF that year alone - roughly one in every 32 births across the UK. Behind that headline figure lies a quieter but equally significant shift: the growing role of donors. Today, around 1 in 137 UK births involves a donor egg or donor sperm.
The reason so many patients are turning to donor eggs is simple, and the numbers make a compelling case. For women aged 43 to 50, birth rates are around 5% when using their own eggs, compared with over 30% when using donor eggs. This difference, for many, transforms IVF from a long shot into a realistic path to parenthood.
Yet as demand has grown, supply has struggled to keep up. New donor registrations have actually declined over the same period — from 1,495 in 2019 to 1,392 in 2023 — even as more patients than ever turn to donor treatment. It's a widening gap that touches everyone on the waiting list, but its effects are not felt equally. For patients hoping to be matched with a donor who shares their own ethnic background, that gap becomes a much longer, harder wait.

Why South Asian Patients Wait Longer

HFEA data shows around 88% of UK egg donors are White, while Asian donors make up roughly 4 to 5% of the total, well below the proportion of Asian women of donor age in the population. Around four in five patients who have used donor eggs, sperm or embryos say it matters that the donor's ethnicity matches their own, so South Asian patients are drawing from a very small pool relative to demand. In practice, this can mean waits of two to three years for a matched donor, well beyond what many other patients face.
The roots of this shortage lie deeper than statistics alone can explain. Research into donor conception among UK minority ethnic groups, including work by the Progress Educational Trust, points to a persistent stigma around third-party reproduction. It highlights concerns that using eggs or sperm from outside a marriage crosses culturally and religiously significant boundaries around family and lineage. Infertility itself remains a difficult subject within many South Asian households, let alone the prospect of donating eggs to a stranger.
These attitudes are rooted in deeply held cultural and religious values and deserve to be understood as such. But their practical effect remains the same: fewer South Asian donors coming forward, even as demand for ethnically matched donors continues to rise.

The Emotional Toll of Waiting

For patients already navigating the physical and financial strain of fertility treatment, a multi-year wait for a donor brings an underestimated burden. Some feel a quiet isolation, since donor conception is rarely spoken about openly within their communities, leaving them without the peer support other patients find more readily. Others face a harder decision still: whether to keep waiting for a matched donor, or to proceed with a donor from a different ethnic background - a choice that carries its own emotional weight, touching on questions of identity and family resemblance for the future child.

Why It Pays to Explore Options Early

Because ethnically matched donor waits are so much longer for South Asian patients, starting the conversation early gives patients far greater control over their journey. Time is the real advantage here: an early consultation allows patients to understand realistic waiting times, explore every available donor pathway, and reach decisions that are informed rather than rushed.
Early conversations also let clinics properly assess each patient's treatment history, medical circumstances and personal preferences, to determine whether donor eggs might be the right option sooner rather than later.

Looking Beyond the UK Donor Pool

For a growing number of South Asian patients, the solution is increasingly found beyond UK borders. Partnering with fertility programmes overseas can open access to a considerably larger and more ethnically diverse donor pool than is currently available at home — often with far shorter waiting times as a result.
This is not a decision to take lightly. An international pathway demands careful attention to clinical standards, donor screening, legal frameworks and patient safeguarding. All of these vary significantly from country to country. But if done well, an international pathway offers something many South Asian patients have struggled to find at home: realistic access to a donor match that truly reflects their own background, without the multi-year wait that so often stands in the way.

How Alma Fertility and The Medical Travel Company Can Help

For patients ready to take this step, having trusted guidance, from first consultation to treatment and beyond, makes all the difference.
Alma Fertility has partnered with The Medical Travel Company (TMTC) to help patients explore treatment abroad safely and with proper clinical oversight at every step. Through this partnership, patients benefit from personalised fertility care from Alma Fertility, alongside a fully coordinated international pathway with TMTC. From the first consultation through to treatment planning, donor matching and ongoing support, both teams work together to provide dedicated guidance at every stage of the journey.

Who it may help

Donor egg treatment may be worth considering for patients who are unable to use their own eggs, who have had unsuccessful treatment using their own eggs or who have been advised that donor eggs may offer a more suitable route to pregnancy. This includes:
  • Women with reduced ovarian reserve or premature ovarian insufficiency
  • Patients who have experienced repeated unsuccessful IVF cycles
  • Patients affected by age-related egg quality concerns
  • People who may need donor eggs for medical or genetic reasons
  • Couples or individuals exploring a carefully supported international treatment pathway

A clear, personal and supportive approach

The pathway is designed to feel informed, not overwhelming. Alma Fertility provides the initial consultation, fertility assessment and counselling guidance where appropriate, alongside ongoing coordination, so patients understand each stage fully before making any decision. TMTC, in turn, supports the treatment pathway in India, including donor coordination, clinic-based care and logistics.
The result is a truly integrated care pathway built on communication, reassurance, and clinical oversight. From the initial consultation and assessment of suitability to treatment planning, donor coordination and care in India, patients are supported every step of the way, before, during and after their journey.

Donor Matching: Screening, Safeguarding and Reassurance

Donor egg treatment requires careful consideration, clear information and appropriate safeguards at every stage. Through this partnership, patients are supported by a process that places donor screening, patient preparation and responsible clinical practice firmly at the centre of care. The team explains exactly what screening is undertaken, how matching is approached, and what legal or practical points patients need to understand before proceeding.
Exact treatment steps, donor availability and regulatory requirements can vary from case to case, which is why the clinical team provides personalised advice based on each patient's individual circumstances. For South Asian couples facing long waits in the UK, understanding every available option early can make all the difference. Whether treatment ultimately takes place in the UK or overseas, the goal is the same: helping patients make informed decisions, at the right time, with confidence and the support they need to move forward.
References:
  • HFEA - Fertility treatment 2023: trends and figures

Related Articles

Decorative Underline Accent TMTC

Ready to open the door to better health?

Decorative Underline Accent TMTC
Get in Touch Image TMTC